Cart
sales@molnova.com
Chrysophanic Acid
CAS No. 481-74-3
Chrysophanic Acid( Chrysophanic Acid | NSC 37132 | NSC 646567 | Turkey Rhubarb )
Catalog No. M14613 CAS No. 481-74-3
Extracted from Rheum palmatum L.;Suitability:Boiling ethanol,benzene,chloroform,ether,acetic acid and acetone.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 50MG | 29 | In Stock |
|
| 100MG | 43 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameChrysophanic Acid
-
NoteResearch use only, not for human use.
-
Brief DescriptionExtracted from Rheum palmatum L.;Suitability:Boiling ethanol,benzene,chloroform,ether,acetic acid and acetone.
-
DescriptionExtracted from Rheum palmatum L.;Suitability:Boiling ethanol,benzene,chloroform,ether,acetic acid and acetone;Store the product in sealed,cool and dry condition.
-
In Vitro——
-
In Vivo——
-
SynonymsChrysophanic Acid | NSC 37132 | NSC 646567 | Turkey Rhubarb
-
PathwayAngiogenesis
-
TargetEGFR
-
RecptorEGFR
-
Research AreaCancer
-
Indication——
Chemical Information
-
CAS Number481-74-3
-
Formula Weight254.24
-
Molecular FormulaC15H10O4
-
Purity>98% (HPLC)
-
SolubilityDMSO: 5 mg/mL warmed (19.66 mM)
-
SMILESO=C1C2=C(C=CC=C2O)C(C3=CC(C)=CC(O)=C13)=O
-
Chemical Name1,8-dihydroxy-3-methylanthracene-9,10-dione
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Lee MS, et al. PhytOthers Res, 2011, 25(6), 833-837.
molnova catalog
related products
-
Varlitinib
Varlitinib is a selective and potent ErbB1(EGFR) and ErbB2(HER2) inhibitor with IC50 of 7 nM and 2 nM respectively. Phase 2.
-
Sapitinib
Sapitinib (AZD-8931, AZD8931) is a equipotent, reversible inhibitor of EGFR, ErbB2 and ErbB3 with IC50 of 4. 3 and 4 nM (phosphorylation inhibition), respectively.
-
Afatinib dimaleate
An irreversible, dual EGFR/HER2 inhibitor with IC50 of 0.5/0.4/10/14 nM for wt EGFR/EGFR L858R/EGFR L858R+T790M/HER2 respectively.
